Teknos, Theodoros N <br/><br/>
A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.  [electronic resource] 

 -  Investigational new drugs  08 2019 
 - 702-710 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-018-0696-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia--chemically induced<br/>Antineoplastic Agents--administration & dosage<br/>Chemoradiotherapy--adverse effects<br/>Cisplatin--administration & dosage<br/>Drug Eruptions<br/>Female<br/>Head and Neck Neoplasms--therapy<br/>Humans<br/>Leukopenia--chemically induced<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Mucositis--chemically induced<br/>Squamous Cell Carcinoma of Head and Neck--therapy<br/>Survival Analysis<br/>Treatment Outcome<br/>Vorinostat--administration & dosage<br/>Weight Loss